Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 102

Similar articles for PubMed (Select 20159561)


AFF4, a component of the ELL/P-TEFb elongation complex and a shared subunit of MLL chimeras, can link transcription elongation to leukemia.

Lin C, Smith ER, Takahashi H, Lai KC, Martin-Brown S, Florens L, Washburn MP, Conaway JW, Conaway RC, Shilatifard A.

Mol Cell. 2010 Feb 12;37(3):429-37. doi: 10.1016/j.molcel.2010.01.026.


The super elongation complex family of RNA polymerase II elongation factors: gene target specificity and transcriptional output.

Luo Z, Lin C, Guest E, Garrett AS, Mohaghegh N, Swanson S, Marshall S, Florens L, Washburn MP, Shilatifard A.

Mol Cell Biol. 2012 Jul;32(13):2608-17. doi: 10.1128/MCB.00182-12. Epub 2012 Apr 30.


The super elongation complex (SEC) and MLL in development and disease.

Smith E, Lin C, Shilatifard A.

Genes Dev. 2011 Apr 1;25(7):661-72. doi: 10.1101/gad.2015411. Review.


The super elongation complex (SEC) family in transcriptional control.

Luo Z, Lin C, Shilatifard A.

Nat Rev Mol Cell Biol. 2012 Sep;13(9):543-7. doi: 10.1038/nrm3417. Epub 2012 Aug 16. Review.


Function of leukemogenic mixed lineage leukemia 1 (MLL) fusion proteins through distinct partner protein complexes.

Biswas D, Milne TA, Basrur V, Kim J, Elenitoba-Johnson KS, Allis CD, Roeder RG.

Proc Natl Acad Sci U S A. 2011 Sep 20;108(38):15751-6. doi: 10.1073/pnas.1111498108. Epub 2011 Sep 6.


Licensed to elongate: a molecular mechanism for MLL-based leukaemogenesis.

Mohan M, Lin C, Guest E, Shilatifard A.

Nat Rev Cancer. 2010 Oct;10(10):721-8. doi: 10.1038/nrc2915. Epub 2010 Sep 16.


Human Polymerase-Associated Factor complex (PAFc) connects the Super Elongation Complex (SEC) to RNA polymerase II on chromatin.

He N, Chan CK, Sobhian B, Chou S, Xue Y, Liu M, Alber T, Benkirane M, Zhou Q.

Proc Natl Acad Sci U S A. 2011 Sep 6;108(36):E636-45. doi: 10.1073/pnas.1107107108. Epub 2011 Aug 22.


CBX8, a polycomb group protein, is essential for MLL-AF9-induced leukemogenesis.

Tan J, Jones M, Koseki H, Nakayama M, Muntean AG, Maillard I, Hess JL.

Cancer Cell. 2011 Nov 15;20(5):563-75. doi: 10.1016/j.ccr.2011.09.008.


A higher-order complex containing AF4 and ENL family proteins with P-TEFb facilitates oncogenic and physiologic MLL-dependent transcription.

Yokoyama A, Lin M, Naresh A, Kitabayashi I, Cleary ML.

Cancer Cell. 2010 Feb 17;17(2):198-212. doi: 10.1016/j.ccr.2009.12.040.


The elongation domain of ELL is dispensable but its ELL-associated factor 1 interaction domain is essential for MLL-ELL-induced leukemogenesis.

Luo RT, Lavau C, Du C, Simone F, Polak PE, Kawamata S, Thirman MJ.

Mol Cell Biol. 2001 Aug;21(16):5678-87.


HIV-1 Tat assembles a multifunctional transcription elongation complex and stably associates with the 7SK snRNP.

Sobhian B, Laguette N, Yatim A, Nakamura M, Levy Y, Kiernan R, Benkirane M.

Mol Cell. 2010 May 14;38(3):439-51. doi: 10.1016/j.molcel.2010.04.012.


A carboxy-terminal domain of ELL is required and sufficient for immortalization of myeloid progenitors by MLL-ELL.

DiMartino JF, Miller T, Ayton PM, Landewe T, Hess JL, Cleary ML, Shilatifard A.

Blood. 2000 Dec 1;96(12):3887-93.


The little elongation complex regulates small nuclear RNA transcription.

Smith ER, Lin C, Garrett AS, Thornton J, Mohaghegh N, Hu D, Jackson J, Saraf A, Swanson SK, Seidel C, Florens L, Washburn MP, Eissenberg JC, Shilatifard A.

Mol Cell. 2011 Dec 23;44(6):954-65. doi: 10.1016/j.molcel.2011.12.008.


HIV-1 Tat and host AFF4 recruit two transcription elongation factors into a bifunctional complex for coordinated activation of HIV-1 transcription.

He N, Liu M, Hsu J, Xue Y, Chou S, Burlingame A, Krogan NJ, Alber T, Zhou Q.

Mol Cell. 2010 May 14;38(3):428-38. doi: 10.1016/j.molcel.2010.04.013.


Mixed lineage leukemia: roles in human malignancies and potential therapy.

Marschalek R.

FEBS J. 2010 Apr;277(8):1822-31. doi: 10.1111/j.1742-4658.2010.07608.x. Epub 2010 Mar 4. Review.


Complex three-way translocation involving MLL, ELL, RREB1, and CMAHP genes in an infant with acute myeloid leukemia and t(6;19;11)(p22.2;p13.1;q23.3).

Tuborgh A, Meyer C, Marschalek R, Preiss B, Hasle H, Kjeldsen E.

Cytogenet Genome Res. 2013;141(1):7-15. doi: 10.1159/000351224. Epub 2013 May 30.


ELL and EAF1 are Cajal body components that are disrupted in MLL-ELL leukemia.

Polak PE, Simone F, Kaberlein JJ, Luo RT, Thirman MJ.

Mol Biol Cell. 2003 Apr;14(4):1517-28. Erratum in: Mol Biol Cell.2003 May;14(5):following table of contents.


A novel variant form of MLL-ELL fusion transcript with t(11;19)(q23;p13.1) in chronic myelomonocytic leukemia transforming to acute myeloid leukemia.

Kakihana K, Kubo F, Wakabayashi S, Kurosu T, Miki T, Murakami N, Miura O.

Cancer Genet Cytogenet. 2008 Jul 15;184(2):109-12. doi: 10.1016/j.cancergencyto.2008.04.001.

Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk